lobbying_activities: 2520447

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2520447	df36604e-8d98-42e7-9e0e-7f305e32dade	Q3	NVG, LLC	76833	AMERICAN ASSOCIATION FOR JUSTICE	2020	third_quarter	HCR	Section 213 of S.1895, the Lower Health Care Cost Act, related to modernizing the labeling of certain generic drugs; H.R. 5668, the MODERN Labeling Act of 2020; H.R.5279, Cosmetic Safety Enhancement Act of 2019; S. 3872 and HR 7269, Promising Pathways Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-10-19T16:57:23.623000-04:00